Abstract
For the purpose of introducing nucleic acids into cells, cationic polymers have been steadily improved as gene carriers. This has resulted in improved polymer-based gene transfer formulations, termed polyplexes, which efficiently transfect cell cultures and also have shown encouraging gene transfer potential in in vivo administration. Targeted delivery to liver, lung, tumor, or other tissues has been achieved in experimental animals by localized or systemic application. Therapeutic effect has been demonstrated, although efficiencies are still too low to justify clinical use. The limitations of first-generation polymeric carriers (modest activity and significant toxicity) have been addressed by developments of new biodegradable polycations, incorporation of targeting and intracellular transport functions, and polyplex formulations that avoid unspecific adverse interactions with the host. A key future step will be the development of polyplexes into artificial viruses, with virus-like entry functions presented by smart polymers and polymer conjugates. These polymers have to sense their biologic microenvironment, respond in a more dynamic manner to alterations in pH, ionic or redox environment, undergoing programmed structural changes compatible with the different gene delivery steps.
Similar content being viewed by others
REFERENCES
C. E. Smull and E. H. Ludwig. Enhancement of the plaque forming capacity of poliovirus ribonucleic acid with basic proteins. J. Bacteriol. 84:1035-1040 (1962).
A. Vaheri and J. S. Pagano. Infectious poliovirus RNA: a sensitive method of assay. Virology 27:434-436 (1965).
P. L. Felgner, Y. Barenholz, J. P. Behr, S. H. Cheng, P. Cullis, L. Huang, J. A. Jessee, L. Seymour, F. Szoka, A. R. Thierry, E. Wagner, and G. Wu. Nomenclature for synthetic gene delivery systems. Hum. Gene Ther. 8:511-512 (1997).
S. C. De Smedt, J. Demeester, and W. E. Hennink. Cationic polymer based gene delivery systems. Pharm. Res. 17:113-126 (2000).
M. D. Brown, A. G. Schatzlein, and I. F. Uchegbu. Gene delivery with synthetic (non viral) carriers. Int. J. Pharm. 229:1-21 (2001).
S. Han, R. I. Mahato, Y. K. Sung, and S. W. Kim. Development of biomaterials for gene therapy. Mol Ther. 2:302-317 (2000).
E. Wagner, C. Plank, K. Zatloukal, M. Cotten, and M. L. Birnstiel. Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. Proc. Natl. Acad. Sci. USA 89:7934-7938 (1992).
S. M. Zou, P. Erbacher, J. S. Remy, and J. P. Behr. Systemic linear polyethylenimine (L-PEI)-mediated gene delivery in the mouse. J. Gene Med. 2:128-134 (2000).
G. Y. Wu and C. H. Wu. Receptor-mediated gene delivery and expression in vivo. J. Biol. Chem. 262:14621-14624 (1988).
N. R. Chowdhury, C. H. Wu, G. Y. Wu, P. C. Yerneni, V. R. Bommineni, and J. R. Chowdhury. Fate of DNA targeted to the liver by asialoglycoprotein receptor-mediated endocytosis in vivo. Prolonged persistence in cytoplasmic vesicles after partial hepatectomy. J. Biol. Chem. 268:11265-11271 (1993).
G. Y. Wu, J. M. Wilson, F. Shalaby, M. Grossman, D. A. Shafritz, and C. H. Wu. Receptor-mediated gene delivery in vivo. Partial correction of genetic analbuminemia in Nagase rats. J. Biol. Chem. 266:14338-14342 (1991).
J. M. Wilson, M. Grossman, C. H. Wu, N. R. Chowdhury, G. Y. Wu, and J. R. Chowdhury. Hepatocyte-directed gene transfer in vivo leads to transient improvement of hypercholesterolemia in low density lipoprotein receptor-deficient rabbits. J. Biol. Chem. 267:963-967 (1992).
J. C. Perales, T. Ferkol, H. Beegen, O. D. Ratnoff, and R. W. Hanson. Gene transfer in vivo: sustained expression and regulation of genes introduced into the liver by receptor-targeted uptake. Proc. Natl. Acad. Sci. USA 91:4086-4090 (1994).
M. Nishikawa, M. Yamauchi, K. Morimoto, E. Ishida, Y. Takakura, and M. Hashida. Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system. Gene Ther. 7:548-555 (2000).
K. Morimoto, M. Nishikawa, S. Kawakami, T. Nakano, Y. Hattori, S. Fumoto, F. Yamashita, and M. Hashida. Molecular weight-dependent gene transfection activity of unmodified and galactosylated polyethyleneimine on hepatoma cells and mouse liver. Mol Ther. 7:254-261 (2003).
H. K. Nguyen, P. Lemieux, S. V. Vinogradov, C. L. Gebhart, N. Guérin, G. Paradis, T. K. Bronich, V. Y. Alakhov, and A. V. Kabanov. Evaluation of polyether-polyethyleneimine graft copolymers as gene transfer agents. Gene Ther. 7:126-138 (2000).
T. Ferkol, J. C. Perales, E. Eckman, C. S. Kaetzel, R. W. Hanson, and P. B. Davis. Gene transfer into the airway epithelium of animals by targeting the polymeric immunoglobulin receptor. J. Clin. Invest. 95:493-502 (1995).
A. G. Ziady, T. Ferkol, D. V. Dawson, D. H. Perlmutter, and P. B. Davis. Chain length of the polylysine in receptor-targeted gene transfer complexes affects duration of reporter gene expression both in vitro and in vivo. J. Biol. Chem. 274:4908-4916 (1999).
D. Goula, N. Becker, G. F. Lemkine, P. Normandie, J. Rodrigues, S. Mantero, G. Levi, and B. A. Demeneix. Rapid crossing of the pulmonary endothelial barrier by polyethylenimine/DNA complexes. Gene Ther. 7:499-504 (2000).
L. Wightman, R. Kircheis, V. Rossler, S. Carotta, R. Ruzicka, M. Kursa, and E. Wagner. Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J. Gene Med. 3:362-372 (2001).
P. Chollet, M. C. Favrot, A. Hurbin, and J. L. Coll. Side-effects of a systemic injection of linear polyethylenimine-DNA complexes. J. Gene Med. 4:84-91 (2002).
A. Kichler, M. Chillon, C. Leborgne, O. Danos, and B. Frisch. Intranasal gene delivery with a polyethylenimine-PEG conjugate. J. Control Release 81:379-388 (2002).
C. Rudolph, J. Lausier, S. Naundorf, and R. H. Muller. and J. Rosenecker. In vivo gene delivery to the lung using polyethylenimine and fractured polyamidoamine dendrimers. J. Gene Med. 2:269-278 (2000).
A. Gautam, J. C. Waldrep, C. L. Densmore, N. Koshkina, S. Melton, L. Roberts, B. Gilbert, and V. Knight. Growth inhibition of established B16-F10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin. Gene Ther. 9:353-357 (2002).
J. L. Coll, P. Chollet, E. Brambilla, D. Desplanques, J. P. Behr, and M. Favrot. In vivo delivery to tumors of DNA complexed with linear polyethylenimine. Hum. Gene Ther. 10:1659-1666 (1999).
F. J. Verbaan, C. Oussoren, I. M. van Dam, Y. Takakura, M. Hashida, D. J. Crommelin, W. E. Hennink, and G. Storm. The fate of poly(2-dimethyl amino ethyl)methacrylate-based polyplexes after intravenous administration. Int. J. Pharm. 214:99-101 (2001).
C. Plank, K. Mechtler, F. J. Szoka, and E. Wagner. Activation of the complement system by synthetic DNA complexes: A potential barrier for intravenous gene delivery. Hum. Gene Ther. 7:1437-1446 (1996).
M. Ogris, S. Brunner, S. Schuller, R. Kircheis, and E. Wagner. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. 6:595-605 (1999).
C. M. Ward, M. L. Read, and L. W. Seymour. Systemic circulation of poly(L-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for human gene therapy. Blood 97:2221-2229 (2001).
M. Kursa, G. F. Walker, V. Roessler, M. Ogris, W. Roedl, R. Kircheis, and E. Wagner. Novel Shielded Transferrin-Polyethylene Glycol-Polyethylenimine/DNA Complexes for Systemic Tumor-Targeted Gene Transfer. Bioconjug. Chem. 14:222-231 (2003).
R. Kircheis, L. Wightman, A. Schreiber, B. Robitza, V. Rossler, M. Kursa, and E. Wagner. Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application. Gene Ther. 8:28-40 (2001).
M. F. Wolschek, C. Thallinger, M. Kursa, V. Rossler, M. Allen, C. Lichtenberger, R. Kircheis, T. Lucas, M. Willheim, W. Reinisch, A. Gangl, E. Wagner, and B. Jansen. Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice. Hepatology 36:1106-1114 (2002).
R. Kircheis, E. Ostermann, M. F. Wolschek, C. Lichtenberger, C. Magin-Lachmann, L. Wightman, M. Kursa, and E. Wagner. Tumor-targeted gene delivery of tumor necrosis factor-alpha induces tumor necrosis and tumor regression without systemic toxicity. Cancer Gene Ther. 9:673-680 (2002).
D. Fischer, T. Bieber, Y. Li, H. P. Elsasser, and T. Kissel. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm. Res. 16:1273-1279 (1999).
T. Bettinger, R. C. Carlisle, M. L. Read, M. Ogris, and L. W. Seymour. Peptide-mediated RNA delivery: a novel approach for enhanced transfection of primary and post-mitotic cells. Nucleic Acids Res. 29:3882-3891 (2001).
A. Aigner, D. Fischer, T. Merdan, C. Brus, T. Kissel, and F. Czubayko. Delivery of unmodified bioactive ribozymes by an RNA-stabilizing polyethylenimine (LMW-PEI) efficiently down-regulates gene expression. Gene Ther. 9:1700-1707 (2002).
G. F. Lemkine, D. Goula, N. Becker, L. Paleari, G. Levi, and B. A. Demeneix. Optimisation of polyethylenimine-based gene delivery to mouse brain. J. Drug Target. 7:305-312 (1999).
A. Boletta, A. Benigni, J. Lutz, G. Remuzzi, M. R. Soria, and L. Monaco. Nonviral gene delivery to the rat kidney with polyethylenimine. Hum. Gene Ther. 8:1243-1251 (1997).
A. Prokop, E. Kozlov, W. Moore, and J. M. Davidson. Maximizing the in vivo efficiency of gene transfer by means of nonviral polymeric gene delivery vehicles. J. Pharm. Sci. 91:67-76 (2002).
P. Lemieux, N. Guerin, G. Paradis, R. Proulx, L. Chistyakova, A. Kabanov, and V. Alakhov. A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle. Gene Ther. 7:986-991 (2000).
D. Putnam, C. A. Gentry, D. W. Pack, and R. Langer. Polymer-based gene delivery with low cytotoxicity by a unique balance of side-chain termini. Proc. Natl. Acad. Sci. USA 98:1200-1205 (2001).
M. Bello Roufai and P. Midoux. Histidylated polylysine as DNA vector: elevation of the imidazole protonation and reduced cellular uptake without change in the polyfection efficiency of serum stabilized negative polyplexes. Bioconjug. Chem. 12:92-99 (2001).
M. Thomas and A. M. Klibanov. Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells. Proc. Natl. Acad. Sci. USA 99:14640-14645 (2002).
Y. B. Lim, S. O. Han, H. U. Kong, Y. Lee, J. S. Park, B. Jeong, and S. W. Kim. Biodegradable polyester, poly[alpha-(4-aminobutyl)-L-glycolic acid], as a non-toxic gene carrier. Pharm. Res. 17:811-816 (2000).
Y. Lim, Y. H. Choi, and J. Park. A self-destroying polycationic polymer: biodegradable poly(4-hydroxy-L-proline ester). J. Am. Chem. Soc. 121:5633-5639 (1999).
D. L. McKenzie, E. Smiley, K. Y. Kwok, and K. G. Rice. Low molecular weight disulfide cross-linking peptides as nonviral gene delivery carriers. Bioconjug. Chem. 11:901-909 (2000).
D. Oupicky, R. C. Carlisle, and L. W. Seymour. Triggered intracellular activation of disulfide crosslinked polyelectrolyte gene delivery complexes with extended systemic circulation in vivo. Gene Ther. 8:713-724 (2001).
M. A. Gosselin, W. Guo, and R. J. Lee. Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine. Bioconjug. Chem. 12:989-994 (2001).
Y. B. Lim, S. M. Kim, H. Suh, and J. S. Park. Biodegradable, endosome disruptive, and cationic network-type polymer as a highly efficient and nontoxic gene delivery carrier. Bioconjug. Chem. 13:952-957 (2002).
D. B. Rozema, K. Ekena, D. L. Lewis, A. G. Loomis, and J. A. Wolff. Endosomolysis by Masking of a Membrane-Active Agent (EMMA) for Cytoplasmic Release of Macromolecules. Bioconjug. Chem. 14:51-57 (2003).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wagner, E. Strategies to Improve DNA Polyplexes for in Vivo Gene Transfer: Will “Artificial Viruses” Be the Answer?. Pharm Res 21, 8–14 (2004). https://doi.org/10.1023/B:PHAM.0000012146.04068.56
Issue Date:
DOI: https://doi.org/10.1023/B:PHAM.0000012146.04068.56